Haemonetics Corp (HAE)

Sector: Healthcare
Industry: Surgical & Medical Instruments & Apparatus
Country: United States
Exchange: NYSE
Market cap: $4.93B

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Latest financial period: June 27, 2026
Filed with the SEC: August 6, 2026
Estimated earnings date: November 5, 2026

Menu

Home

Compare

Next Earnings Reports

How this site works

Terms of use

About